As with PGE2, GM-CSF has also been identified as being elevated in asthma [37] and has been shown to be a contributor to airway inflammation and hyperresponsiveness [38]. While our studies are the first to identify GM-CSF as being elevated systemically, previous studies have shown GM-CSF up-regulation locally in allergic and non-allergic polyp tissue compared to turbinate [39]. However, the role of both of these factors in Selleckchem Ixazomib CRSsNP and CRSwNP remains to be identified. In addition to examination of immune parameters,

the impact of VD3 on bone erosion in CRS was investigated. Patients with more severe forms of CRS that present with bone erosion into the orbit and/or skull base demonstrated more severe VD3 deficiencies. These results echo similar findings in other diseases, such as rheumatoid arthritis, that report a relationship between VD3 receptor polymorphisms and accelerated bone loss [40]. It is unclear if VD3 deficiencies lead to systemic abnormalities of bone metabolism or if they even play a major role in localized bone loss within the sinonasal cavity. VD3 targets many of the same DC regulatory pathways as corticosteroids, such as prednisone, one of the most commonly prescribed treatments for CRS. Based on this, it could be suggested that supplementation

with VD3 in CRSwNP and AFRS may be analogous to replacing one’s natural prednisone. Based on the results of the above-mentioned studies and the results presented find more here, there is increasing evidence to support a role for VD3 as a key player in the immunopathology of CRSwNP and AFRS. The authors would like to thank Helen eltoprazine Accerbi RN for her technical assistance with these studies. These studies were supported by grants to R.J.S. and J.K.M. from the Flight Attendant Medical Research Institute. None of the authors listed have any potential conflicts to disclose

related to the research presented herein. “
“Phagocytes, including neutrophils, monocytes, and macrophages, play a crucial role in host defense by recognition and elimination of invading pathogens. Phagocytic cells produce reactive oxygen species (ROS), inflammatory cytokines, and chemokines, leading to bacterial killing and to recruitment and activation of additional immune cells. However, inflammatory mediators are potentially harmful for the host and their production is therefore tightly controlled by multiple regulatory mechanisms. One such mechanism is immune suppression by immune inhibitory receptors, which are increasingly acknowledged as potent regulators of the immune response. So far, research has focused on the role of these receptors in the regulation of NK cells, B cells, and T cells. Importantly, an accumulating number of inhibitory receptors have been identified on phagocytes.